Safety analysis of intravenous amiodarone in wolff parkinson white syndrome with atrial fibrillation / 解放军医学杂志
Article
in Zh
| WPRIM
| ID: wpr-556641
Responsible library:
WPRO
ABSTRACT
Objectives To evaluate the safety of intravenous amiodarone in patients with atrial fibrillation and rapid ventricular response via an accessory pathway. Methods Sixteen patients with Wolff Parkinson White syndrome (W P W group) and 16 patients with concealed accessory pathway (control group) were included. The anterograde effective refractory period of accessory pathway (ERP AP ) in W P W group and the effective refractory period of atrioventricular node (ERP AVN ) in control group were measured. Then 150mg of amiodarone was injected intravenously in 10min, the ERP AP and ERP AVN were remeasured 10min later. Results After amiodarone injection, ERP AP was increased slightly ( P
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Medical Journal of Chinese People's Liberation Army
Year:
1981
Type:
Article